|
Btk Inhibitors — Pointing the Way to the Future of Targeted Therapies?
|
|
Mannkind
|
May 08, 2012 08:15PM
|
|
Bullish Insider Buying Activity Surfacing Among These Names In Real Estate, Heal
|
|
Mannkind
|
Apr 16, 2013 03:00PM
|
|
Buy or Sell?MannKind Under the Microscope
|
|
Mannkind
|
Mar 13, 2013 10:20AM
|
|
Buy, Sell, or Hold: MannKind
|
|
Mannkind
|
Sep 17, 2012 09:37AM
|
|
Buy,Sell,or Hold:MannKind
|
|
Mannkind
|
Jun 29, 2012 04:24PM
|
|
Buying High the New Winning Investment Strategy?
|
1
|
Mannkind
|
Jun 12, 2013 01:33PM
|
|
Comment from "MannKind: A Pure Speculative Bet'
|
3
|
Mannkind
|
Mar 22, 2013 09:47AM
|
|
Commit To Buy MannKind Corp At $2.50, Earn 28%
|
|
Mannkind
|
May 23, 2013 05:35PM
|
|
Companies Looking Towards Future Revenue with New Diabetes Therapies
|
1
|
Mannkind
|
Mar 28, 2012 07:06PM
|
|
Companies That Are Fighting The Insulin Battle
|
|
Mannkind
|
Jun 13, 2012 04:22PM
|
|
Congratulations MNKD
|
|
Mannkind
|
May 11, 2012 02:40PM
|
|
Cowen and Company
|
1
|
Mannkind
|
Feb 20, 2013 11:51AM
|
|
Cramer
|
|
Mannkind
|
Jul 17, 2013 12:37AM
|
|
Cramer
|
|
Mannkind
|
Aug 13, 2013 09:51PM
|
|
Cramer:
|
|
Mannkind
|
Mar 27, 2013 09:59AM
|
|
Deals of the week:Tolero introduces itself in"double jointed" deal with MannKind
|
1
|
Mannkind
|
May 04, 2012 04:16PM
|
|
Debate on diabetes drugs gathers pace
|
|
Mannkind
|
Apr 30, 2012 01:46PM
|
|
Debt Burden Makes Horizon Pharma An Attractive Short
|
|
Mannkind
|
Jul 26, 2012 08:12AM
|
|
December,2013
|
|
Mannkind
|
Jul 14, 2013 10:20PM
|
|
Diabetes Drugs Market Will Reach $55.3bn in 2017, With Further Growth to 2023,
|
|
Mannkind
|
May 07, 2013 09:55AM
|
